FIELD: medicine.
SUBSTANCE: invention relates to a compound selected from:
and
A method for inhibiting and modulating the activity of aldosterone synthase metalloenzyme (CYP11B2), methods for treating diseases or disorders caused by such a metalloenzyme, and a pharmaceutical composition are also proposed.
EFFECT: proposed compounds are capable of inhibiting the activity of aldosterone synthase metalloenzymes (CYP11B2) and can be used to treat diseases or disorders caused by such a metalloenzyme.
15 cl, 5 tbl, 137 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUND BASED ON DIHYDRONAPTHYRIDINONE, METHOD OF ITS OBTAINING, AND ITS USE IN MEDICINE | 2021 |
|
RU2809869C1 |
PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
PYRUVATEKINASE MODULATORS AND THEIR USE | 2018 |
|
RU2797518C2 |
(AZA)INDOLE-, BENZOTHIOPHENE- AND BENZOFURAN-3-SULPHONAMIDES | 2017 |
|
RU2767904C2 |
PROTEIN KINASE INHIBITORS FOR ENHANCING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | 2019 |
|
RU2822216C2 |
HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS | 2019 |
|
RU2812128C2 |
NEW SUBSTITUTED BIARYL COMPOUNDS AS INDOLAMINE-2,3-DIOXYGENASE (IDO) INHIBITORS | 2018 |
|
RU2786586C2 |
QUINOLINE DERIVATIVES AS SMO INHIBITORS | 2015 |
|
RU2695815C2 |
CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | 2011 |
|
RU2565596C2 |
COMPOUNDS TARGETING TAU PROTEIN AND RELATED USE THEREOF | 2017 |
|
RU2805523C2 |
Authors
Dates
2022-01-19—Published
2017-12-22—Filed